No Significant Acquisition. The Corporation has not completed a ‘significant acquisition’ (as such term is defined in NI 51-102) requiring disclosure in the Prospectus.
No Significant Acquisition. The Company or any subsidiary (i) has not made any acquisition that is a “significant acquisition” within the meaning of Canadian Securities Laws in its current financial year or prior financial years in respect of which historical and/or pro forma financial statements would be required to be included or incorporated by reference into the Offering Documents under applicable requirements of Canadian Securities Laws, and (ii) does not currently propose to make an acquisition that has progressed to a state where a reasonable person would believe that the likelihood of the acquisition being completed is high, and that would be a “significant acquisition” within the meaning of the Canadian Securities Laws, if completed as of the date of the Offering Documents, and in respect of which historical and/or pro forma financial statements would be required to be included or incorporated by reference into the Offering Documents under applicable requirements of Canadian Securities Laws.
No Significant Acquisition. The transactions contemplated by this Agreement does not constitute a “Significant Acquisition” (as such term is defined in National Instrument 51-102 – Continuous Disclosure Obligations) by BriaCell.
No Significant Acquisition. The Company has not completed a ‘significant acquisition’ (as such term is defined in NI 51‐102) requiring disclosure in the Prospectus. The Company is not engaged in any proposed acquisition of a business or related business that has progressed to a state where a reasonable person would believe that the likelihood of the Company completing the acquisition is high, and that, if completed by the Company, would be a ‘significant acquisition’ (as such term is defined in NI 51‐102).
No Significant Acquisition. During the Pre-Closing Period, neither Parent nor any of its Subsidiaries shall consummate, or enter into any agreement to consummate, by merger or consolidation with, or by purchase of a substantial portion of the assets, stock or equity interests of, or by any other manner, any “significant” acquisition as determined pursuant to 17 CFR 210.35.
